Singapore's Hilleman Labs to develop and produce CEPI-backed Bundibugyo ebolavirus vaccine doses for clinical trials – BioSpectrum Asia
Singapore’s Hilleman Labs to develop and produce CEPI-backed Bundibugyo ebolavirus vaccine doses for clinical trials BioSpectrum AsiaAfrica CDC says…